Know Cancer

or
forgot password

Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines


N/A
N/A
N/A
Not Enrolling
Both
HIV Infections, Healthy

Thank you

Trial Information

Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines


Subjects are healthy adult volunteers either at high risk for HIV infection or already known
to be seropositive, who will donate blood for in vitro tests of T-cell function and in vitro
responses to synthetic peptides corresponding to sequences from HIV proteins.

Inclusion Criteria


Inclusion criteria for the at risk group will be a statement from the donor that he is an
active homosexual or bisexual.

Homosexual donors must not have AIDS.

Type of Study:

Observational

Study Design:

N/A

Authority:

United States: Federal Government

Study ID:

860199

NCT ID:

NCT00001210

Start Date:

November 1986

Completion Date:

September 2000

Related Keywords:

  • HIV Infections
  • Healthy
  • Blood Donors
  • Epitopes
  • HIV
  • Acquired Immunodeficiency Syndrome
  • HIV Infections

Name

Location

National Cancer Institute (NCI)Bethesda, Maryland  20892